Skip to main content
. 2024 Jan 18;35:1–16. doi: 10.1016/j.bioactmat.2024.01.009

Fig. 8.

Fig. 8

Expression of immunofluorescence markers in bone defects after implantation of gel scaffolds. (a) CD31 immunofluorescence staining images of cranial defects after the implantation of scaffold constructs for 4 and 8 weeks. (b) RUNX2 immunofluorescence staining images of cranial defects after the implantation of scaffold constructs for 4 and 8 weeks. (c and d) Quantitative analysis of CD31 immunofluorescence staining for 4 and 8 weeks. (e and f) Quantitative analysis of RUNX2 immunofluorescence staining for 4 and 8 weeks. *p < 0.05, and **p < 0.01.